PANoptosis in intestinal epithelium: its significance in inflammatory bowel disease and a potential novel therapeutic target for natural products

被引:0
|
作者
Zhao, Chuanxiang [1 ]
Lin, Shan [1 ]
机构
[1] Jiangsu Coll Nursing, Inst Med Genet & Reprod Immun, Sch Med Sci & Lab Med, Huaian, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2025年 / 15卷
关键词
inflammatory bowel disease; intestinal epithelium; cell death; PANoptosis; natural products; CELL-DEATH; GASDERMIN D; CYTOCHROME-C; ACTIVATION; APOPTOSIS; CASPASE-8; ALPHA; NECROPTOSIS; PYROPTOSIS; MLKL;
D O I
10.3389/fimmu.2024.1507065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The intestinal epithelium, beyond its role in absorption and digestion, serves as a critical protective mechanical barrier that delineates the luminal contents and the gut microbiota from the lamina propria within resident mucosal immune cells to maintain intestinal homeostasis. The barrier is manifested as a contiguous monolayer of specialized intestinal epithelial cells (IEC), interconnected through tight junctions (TJs). The integrity of this epithelial barrier is of paramount. Consequently, excessive IEC death advances intestinal permeability and as a consequence thereof the translocation of bacteria into the lamina propria, subsequently triggering an inflammatory response, which underpins the clinical disease trajectory of inflammatory bowel disease (IBD). A burgeoning body of evidence illustrates a landscape where IEC undergoes several the model of programmed cell death (PCD) in the pathophysiology and pathogenesis of IBD. Apoptosis, necroptosis, and pyroptosis represent the principal modalities of PCD with intricate specific pathways and molecules. Ample evidence has revealed substantial mechanistic convergence and intricate crosstalk among these three aforementioned forms of cell death, expanding the conceptualization of PANoptosis orchestrated by the PNAoptosome complex. This review provides a concise overview of the molecular mechanisms of apoptosis, necroptosis, and pyroptosis. Furthermore, based on the crosstalk between three cell deaths in IEC, this review details the current knowledge regarding PANoptosis in IEC and its regulation by natural products. Our objective is to broaden the comprehension of innovative molecular mechanisms underlying the pathogenesis of IBD and to furnish a foundation for developing more natural drugs in the treatment of IBD, benefiting both clinical practitioners and research workers.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
    Ashizuka, Shinya
    Inatsu, Haruhiko
    Inagaki-Ohara, Kyoko
    Kita, Toshihiro
    Kitamura, Kazuo
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2013, 14 (04) : 246 - 255
  • [42] Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease
    Liu, Yulan
    Wang, Xiuying
    Hu, Chien-An Andy
    NUTRIENTS, 2017, 9 (09):
  • [43] Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?
    Naftali, Timna
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (10) : 2696 - 2698
  • [44] Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
    Xu, Qiuyun
    Zhou, Xiaorong
    Strober, Warren
    Mao, Liming
    MOLECULES, 2021, 26 (06):
  • [45] Plasma IgA as a biomarker and IL-21 as a potential therapeutic target in Inflammatory Bowel Disease
    Tsai, T.
    Hsu, J. L.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I981 - I982
  • [46] The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target
    Verma, Ankit
    Pittala, Srinivas
    Alhozeel, Belal
    Shteinfer-Kuzmine, Anna
    Ohana, Ehud
    Gupta, Rajeev
    Chung, Jay H.
    Shoshan-Barmatz, Varda
    MOLECULAR THERAPY, 2022, 30 (02) : 726 - 744
  • [47] The Therapeutic Potential of Carbon Monoxide for Inflammatory Bowel Disease
    Takagi, Tomohisa
    Uchiyama, Kazuhiko
    Naito, Yuji
    DIGESTION, 2015, 91 (01) : 13 - 18
  • [48] Intestinal homeostasis and its breakdown in inflammatory bowel disease
    Kevin J. Maloy
    Fiona Powrie
    Nature, 2011, 474 : 298 - 306
  • [49] Intestinal homeostasis and its breakdown in inflammatory bowel disease
    Maloy, Kevin J.
    Powrie, Fiona
    NATURE, 2011, 474 (7351) : 298 - 306
  • [50] TL1A as a therapeutic target in inflammatory bowel disease
    Kokkotis, Georgios
    Bamias, Giorgos
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (06) : 551 - 555